| Institution: | 1. Molecular Neuropharmacology Laboratory, Department of Neurology, and Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts;2. Center for Neuroscience and Cell Biology, CNC-University of Coimbra, Coimbra, Portugal;3. R.S. Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon;4. Laboratory of Behavioural Neurobiology, Swiss Federal Institute of Technology Zurich, Schwerzenbach, Switzerland;5. Faculty of Medicine, University of Coimbra, Coimbra, Portugal |
